Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

NCT03919552 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

482

Enrollment

OTHER

Sponsor class

Conditions

Cisplatin
Carboplatin
NPC

Interventions

DRUG: Docetaxel,Carboplatin
DRUG: Docetaxel,Cisplatin
RADIATION: Carboplatin-based concurrent chemoradiotherapy
RADIATION: Cisplatin-based concurrent chemoradiotherapy

Sponsor

Nanfang Hospital, Southern Medical University